Skip to main content
Top
Published in: Abdominal Radiology 7/2021

01-07-2021 | Magnetic Resonance Imaging | Pelvis

Are CT and MRI useful tools to distinguish between micropapillary type and typical type of ovarian serous borderline tumors?

Authors: Ya Zhang, Jing Tan, Jiaping Wang, Conghui Ai, Yan Jin, Hongbo Wang, Miaomiao Li, Huimei Zhang, Suixing Zhong

Published in: Abdominal Radiology | Issue 7/2021

Login to get access

Abstract

Purpose

To investigate the computed tomography (CT) and magnetic resonance imaging (MRI) characteristics of ovarian serous borderline tumors (SBTs), and evaluate whether CT and MRI can be used to distinguish micropapillary from typical subtypes.

Materials and methods

We retrospectively reviewed the clinical features and CT and MR imaging findings of 47 patients with SBTs encountered at our institute from September 2013 to December 2019. 30 patients with 58 histologically proven typical SBT and 17 patients with 26 micropapillary SBT were reviewed. Preoperative CT and MR images were evaluated, by two observers in consensus for the laterality, maximum diameter (MD), morphology patterns, internal architecture, attenuation or signal intensity, ADC value, enhancement patterns of solid portions (SP), and extra-ovarian imaging features.

Results

The median age were similar between typical SBT and SBT-MP (32.5 years, 36 years, respectively, P>0.05). Morphology patterns between two subtypes were significantly different on CT and MR images (P < 0.001). Irregular solid tumor (21/37, 56.76%) was the major morphology pattern of typical SBT tumor, while unilocular cyst with mural nodules (14/20, 70%) was the major morphology pattern of SBT-MP on CT images. Similarly, papillary architecture with internal branching (PA&IB) (17/21, 80.95%) was the major morphology pattern of typical SBT tumor, while unilocular cyst with mural nodules (4/6, 66.67%) was the major pattern of SBT-MP on MR images. PA&IB all showed slightly hyperintense papillary architecture with hypointense internal branching on T2-weighted MRI. More calcifications were found in typical SBT (24/37, 64.86%) than SBT-MP mass lesion (6/20, 30%) (P < 0.05). Hemorrhage was less frequently visible in (20/37, 54.05%) typical SBT lessons than SBT-MP mass lesion (18/20, 90%) (P < 0.05). The ovarian preservation is more seen in typical SBT (38/58, 65.52%) than SBT-MP (12/28, 42.86%) in our series (P < 0.05). Mean ADC value of solid portions (papillary architecture and mural nodules) was 1.68 (range from 1.44 to 1.85) × 10−3 mm2/s for typical SBT and 1.62 (range from 1.45 to 1.7) × 10−3 mm2/s for that of SBT-MP. The solid components of the two SBT subtypes showed wash-in appearance enhancements after contrast injection both in CT and MR images except 2 of SBT-MP with no enhancement as complete focal hemorrhage on MR images.

Conclusion

Morphology and internal architecture are two major imaging features that can help to distinguish between SBT-MP and typical SBT.
Literature
1.
go back to reference Kurman R, et al. WHO classification of Tumours of female reproductive organs. No 6. IARC WHO classification of Tumours, fourth edition. IARC: Lyon; 2014. Kurman R, et al. WHO classification of Tumours of female reproductive organs. No 6. IARC WHO classification of Tumours, fourth edition. IARC: Lyon; 2014.
2.
go back to reference May T, Virtanen C, Sharma M, et al. Low malignant potential tumors with micropapillary features. Gynecol Oncol 2010;117(1):9-17.CrossRef May T, Virtanen C, Sharma M, et al. Low malignant potential tumors with micropapillary features. Gynecol Oncol 2010;117(1):9-17.CrossRef
3.
go back to reference Burks RT, Sherman ME, Kurman RJ. Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors. Am J Surg Pathol 1996; 20(11):1319-1330. Burks RT, Sherman ME, Kurman RJ. Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors. Am J Surg Pathol 1996; 20(11):1319-1330.
4.
go back to reference Seidman JD, Kurman RJ. Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases. Am J Surg Pathol 1996; 20(11):1331-1345. Seidman JD, Kurman RJ. Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases. Am J Surg Pathol 1996; 20(11):1331-1345.
5.
go back to reference Wei wei, Guo qing, Tu ping, et al. Clinicopathological features of ovarian serous borderline tumor. J Clin Exp Pathol 2013;29(6):615-620. Wei wei, Guo qing, Tu ping, et al. Clinicopathological features of ovarian serous borderline tumor. J Clin Exp Pathol 2013;29(6):615-620.
6.
go back to reference Nakai G, Yamada T, Yamamoto K, et al. MRI appearance of ovarian serous borderline tumors of the micropapillary type compared to that of typical ovarian serous borderline tumors: radiologic-pathologic correlation. J Ovarian Res 2018;11(1):7.CrossRef Nakai G, Yamada T, Yamamoto K, et al. MRI appearance of ovarian serous borderline tumors of the micropapillary type compared to that of typical ovarian serous borderline tumors: radiologic-pathologic correlation. J Ovarian Res 2018;11(1):7.CrossRef
7.
go back to reference Wong HF, Low J, Chua Y, et al. Ovarian tumors of borderline malignancy: a review of 247 patients from 1991 to 2004. Int J Gynecol Cancer 2007;17(2):342-349.CrossRef Wong HF, Low J, Chua Y, et al. Ovarian tumors of borderline malignancy: a review of 247 patients from 1991 to 2004. Int J Gynecol Cancer 2007;17(2):342-349.CrossRef
8.
go back to reference Tempfer CB, Polterauer S, Bentz EK, et al. Accuracy of intraoperative frozen section analysis in borderline tumors of the ovary: a retrospective analysis of 96 cases and review of the literature. Gynecol Oncol 2007;107:248e52. Tempfer CB, Polterauer S, Bentz EK, et al. Accuracy of intraoperative frozen section analysis in borderline tumors of the ovary: a retrospective analysis of 96 cases and review of the literature. Gynecol Oncol 2007;107:248e52.
9.
go back to reference Morotti M, Menada MV, Gillott DJ, et al. The preoperative diagnosis of borderline ovarian tumors: a review of current literature. Arch Gynecol Obstet 2011; 285(4):1103-1112.CrossRef Morotti M, Menada MV, Gillott DJ, et al. The preoperative diagnosis of borderline ovarian tumors: a review of current literature. Arch Gynecol Obstet 2011; 285(4):1103-1112.CrossRef
10.
go back to reference Makar AP, Kaern J, Kristensen GB, et al. Evaluation of serum CA125 level as a tumor marker in borderline tumors of the ovary. Int J Gynecol Cancer 1993; 3(5):299-303.CrossRef Makar AP, Kaern J, Kristensen GB, et al. Evaluation of serum CA125 level as a tumor marker in borderline tumors of the ovary. Int J Gynecol Cancer 1993; 3(5):299-303.CrossRef
11.
go back to reference Candido Dos Reis F, Moreira de Andrade J, Bighetti S. CA 125 and vascular endothelial growth factor in the differential diagnosis of epithelial ovarian tumors. Gynecol Obstet Invest 2002; 54(3):132-136. Candido Dos Reis F, Moreira de Andrade J, Bighetti S. CA 125 and vascular endothelial growth factor in the differential diagnosis of epithelial ovarian tumors. Gynecol Obstet Invest 2002; 54(3):132-136.
12.
go back to reference Kim SH, Yang DM, Kim SH. Borderline serous surface papillary tumor of the ovary: MRI characteristics. AJR Am J Roentgenol 2005;184(6):1898-1900.CrossRef Kim SH, Yang DM, Kim SH. Borderline serous surface papillary tumor of the ovary: MRI characteristics. AJR Am J Roentgenol 2005;184(6):1898-1900.CrossRef
13.
go back to reference Tanaka YO, Okada S, Satoh T, et al. Ovarian serous surface papillary borderline tumors form sea anemone-like masses. J Magn Reson Imaging 2011;33(3):633-640.CrossRef Tanaka YO, Okada S, Satoh T, et al. Ovarian serous surface papillary borderline tumors form sea anemone-like masses. J Magn Reson Imaging 2011;33(3):633-640.CrossRef
14.
go back to reference Shadbolt C, Kouloyan-Ilic S, Dobrotwir A. Borderline ovarian tumours: MRI features to aid a challenging diagnosis. In: The royal Australian and New Zealand college of radiologists annual scientific meeting; 2013. Shadbolt C, Kouloyan-Ilic S, Dobrotwir A. Borderline ovarian tumours: MRI features to aid a challenging diagnosis. In: The royal Australian and New Zealand college of radiologists annual scientific meeting; 2013.
15.
go back to reference Naqvi J, Nagaraju E, Ahmad S. MRI appearances of pure epithelial papillary serous borderline ovarian tumours. Clinical Radiol 2015;70(4): 424-432.CrossRef Naqvi J, Nagaraju E, Ahmad S. MRI appearances of pure epithelial papillary serous borderline ovarian tumours. Clinical Radiol 2015;70(4): 424-432.CrossRef
16.
go back to reference Outwater EK, Huang AB, Dunton CJ, et al. Papillary projections in ovarian neoplasms: appearance on MRI. J Magn Reson Imaging 1997;7(4):689-695.CrossRef Outwater EK, Huang AB, Dunton CJ, et al. Papillary projections in ovarian neoplasms: appearance on MRI. J Magn Reson Imaging 1997;7(4):689-695.CrossRef
17.
go back to reference Dietel M, Hauptmann S. Serous tumors of low malignant potential of the ovary. 1. Diagnostic pathology. Virchows Arch 2000; 436(5):403-412. Dietel M, Hauptmann S. Serous tumors of low malignant potential of the ovary. 1. Diagnostic pathology. Virchows Arch 2000; 436(5):403-412.
18.
go back to reference Zhao SH, Qiang JW, Zhang GF, et al. Diffusion-weighted MR imaging for differentiating borderline from malignant epithelial tumours of the ovary: pathological correlation. Eur Radiol. 2014; 24(9):2292-2299.CrossRef Zhao SH, Qiang JW, Zhang GF, et al. Diffusion-weighted MR imaging for differentiating borderline from malignant epithelial tumours of the ovary: pathological correlation. Eur Radiol. 2014; 24(9):2292-2299.CrossRef
19.
go back to reference Stevens SK, Hricak H, Stern JL. Ovarian lesions: detection and characterization with gadolinium-enhanced MR imaging at 1.5 T. Radiology 1991;181(2):481-488. Stevens SK, Hricak H, Stern JL. Ovarian lesions: detection and characterization with gadolinium-enhanced MR imaging at 1.5 T. Radiology 1991;181(2):481-488.
20.
go back to reference Woodward PJ, Hosseinzadeh K, Saenger JS. From the archives of the AFIP: radiologic staging of ovarian carcinoma with pathologic correlation. Radiographics 2004;24(1):225-246.CrossRef Woodward PJ, Hosseinzadeh K, Saenger JS. From the archives of the AFIP: radiologic staging of ovarian carcinoma with pathologic correlation. Radiographics 2004;24(1):225-246.CrossRef
21.
go back to reference Kawamoto S, Urban BA, Fishman EK. CT of epithelial ovarian tumors. Radiographics 1999; 19:S85-S102.CrossRef Kawamoto S, Urban BA, Fishman EK. CT of epithelial ovarian tumors. Radiographics 1999; 19:S85-S102.CrossRef
22.
go back to reference Acs G. Serous and mucinous borderline (low malignant potential) tumors of the ovary. Am J Clin Pathol 2005;123: S13-S57.PubMed Acs G. Serous and mucinous borderline (low malignant potential) tumors of the ovary. Am J Clin Pathol 2005;123: S13-S57.PubMed
23.
go back to reference Jung SE, Lee JM, Rha SE, et al. CT and MR imaging of ovarian tumors with emphasis on differential diagnosis. Radiographics 2002;22(6):1305-1325.CrossRef Jung SE, Lee JM, Rha SE, et al. CT and MR imaging of ovarian tumors with emphasis on differential diagnosis. Radiographics 2002;22(6):1305-1325.CrossRef
24.
go back to reference Thomassin-Naggara I, Daraï E, Cuenod CA, et al. Dynamic contrastenhanced magnetic resonance imaging: a useful tool for characterizing ovarian epithelial tumors. J Magn Reson Imaging 2008;28(1):111-120.CrossRef Thomassin-Naggara I, Daraï E, Cuenod CA, et al. Dynamic contrastenhanced magnetic resonance imaging: a useful tool for characterizing ovarian epithelial tumors. J Magn Reson Imaging 2008;28(1):111-120.CrossRef
25.
go back to reference Bazot M, Haouy D, Daraï E, et al. Is MRI a useful tool to distinguish between serous and mucinous borderline ovarian tumours? Clin Radiol 2013;68(1):e1-8.CrossRef Bazot M, Haouy D, Daraï E, et al. Is MRI a useful tool to distinguish between serous and mucinous borderline ovarian tumours? Clin Radiol 2013;68(1):e1-8.CrossRef
26.
go back to reference Burkholz KJ, Wood BP, Zuppan C. Best cases from the AFIP: Borderline papillary serous tumor of the right ovary. Radiographics 2005;25:1689–1692.CrossRef Burkholz KJ, Wood BP, Zuppan C. Best cases from the AFIP: Borderline papillary serous tumor of the right ovary. Radiographics 2005;25:1689–1692.CrossRef
27.
go back to reference Malpica A, Deavers MT, Lu K, et al. Grading ovarian serous carcinoma using a two-tier system. Am J Surg Pathol. 2004; 28(4):496-504.CrossRef Malpica A, Deavers MT, Lu K, et al. Grading ovarian serous carcinoma using a two-tier system. Am J Surg Pathol. 2004; 28(4):496-504.CrossRef
28.
go back to reference Zhao SH, Qiang JW, Zhang GF, et al. MRI appearances of ovarian serous borderline tumor: pathological correlation. J Magn Reson Imaging 2014;40:151-156.CrossRef Zhao SH, Qiang JW, Zhang GF, et al. MRI appearances of ovarian serous borderline tumor: pathological correlation. J Magn Reson Imaging 2014;40:151-156.CrossRef
29.
go back to reference Van Vierzen PB, Massuger LF, Ruys SH, et al. Borderline ovarian malignancy: ultrasound and fast dynamic MR findings. Eur J Radiol 1998;28(2):136-142.CrossRef Van Vierzen PB, Massuger LF, Ruys SH, et al. Borderline ovarian malignancy: ultrasound and fast dynamic MR findings. Eur J Radiol 1998;28(2):136-142.CrossRef
30.
go back to reference Tavassoli FA, Devilee P. International agency for research on cancer. Pathology and genetics of tumours of the breast and female genital organs. Geneva: World Health Organization; 2003. Tavassoli FA, Devilee P. International agency for research on cancer. Pathology and genetics of tumours of the breast and female genital organs. Geneva: World Health Organization; 2003.
31.
go back to reference Bent CL, Sahdev A, Rockall AG, et al. MRI appearances of borderline ovarian tumours. Clin Radiol 2009;64(4):430-438.CrossRef Bent CL, Sahdev A, Rockall AG, et al. MRI appearances of borderline ovarian tumours. Clin Radiol 2009;64(4):430-438.CrossRef
32.
go back to reference Okamoto Y, Tanaka YO, Tsunoda H, et al. Malignant or borderline mucinous cystic neoplasms have a larger number of loculi than mucinous cystadenoma: a retrospective study with MR. J Magn Reson Imaging 2007;26(1):94-99.CrossRef Okamoto Y, Tanaka YO, Tsunoda H, et al. Malignant or borderline mucinous cystic neoplasms have a larger number of loculi than mucinous cystadenoma: a retrospective study with MR. J Magn Reson Imaging 2007;26(1):94-99.CrossRef
33.
go back to reference Nougaret S, Lakhman Y, Molinari N, et al. CT Features of Ovarian Tumors: Defining Key Differences Between Serous Borderline Tumors and Low-Grade Serous Carcinomas. AJR Am J Roentgenol 2018;210(4), 918-926.CrossRef Nougaret S, Lakhman Y, Molinari N, et al. CT Features of Ovarian Tumors: Defining Key Differences Between Serous Borderline Tumors and Low-Grade Serous Carcinomas. AJR Am J Roentgenol 2018;210(4), 918-926.CrossRef
34.
go back to reference Okada S, Ohaki Y, Inoue K, et al. Calcifications in Mucinous and Serous Cystic Ovarian Tumors. J Nippon Med Sch 2005; 72(1):29-33.CrossRef Okada S, Ohaki Y, Inoue K, et al. Calcifications in Mucinous and Serous Cystic Ovarian Tumors. J Nippon Med Sch 2005; 72(1):29-33.CrossRef
35.
go back to reference Dobson M, Carrington BM, Radford JA, et al. The role of computed tomography in the management of ovarian tumours of borderline malignancy. Clin Radiol 1997;52(4):280-283.CrossRef Dobson M, Carrington BM, Radford JA, et al. The role of computed tomography in the management of ovarian tumours of borderline malignancy. Clin Radiol 1997;52(4):280-283.CrossRef
36.
go back to reference Sherman ME, Mink PJ, Curtis R, et al. Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis. Cancer 2004;100(5):1045-1052.CrossRef Sherman ME, Mink PJ, Curtis R, et al. Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis. Cancer 2004;100(5):1045-1052.CrossRef
Metadata
Title
Are CT and MRI useful tools to distinguish between micropapillary type and typical type of ovarian serous borderline tumors?
Authors
Ya Zhang
Jing Tan
Jiaping Wang
Conghui Ai
Yan Jin
Hongbo Wang
Miaomiao Li
Huimei Zhang
Suixing Zhong
Publication date
01-07-2021
Publisher
Springer US
Published in
Abdominal Radiology / Issue 7/2021
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-021-03000-3

Other articles of this Issue 7/2021

Abdominal Radiology 7/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.